Marephar SRL
1.7 FTEThe score of Marephar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +12 % Total assets -8 % Headcount (avg FTE) +42 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Marephar's annual accounts
Filed annual accounts
- Year ended 30 Sep 2025filed on 03 Apr 2026
- Year ended 30 Sep 2024filed on 04 Apr 2025
- Year ended 30 Sep 2023filed on 29 Mar 2024
- Year ended 30 Sep 2022filed on 28 Apr 2023
- Year ended 30 Sep 2021filed on 28 Apr 2022
Marephar's financial analysis
- Solvency35.0%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Marephar
Marephar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.955.109
- VAT number
- BE0479955109
- Peppol
- Registered · 0208:0479955109 · as of 06 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Apr 2003
- Registered office
- 8810 Lichtervelde
- Size
- Micro · 1.7 FTE
- Latest accounts
- 2025 · filed on 03 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Marephar (SRL) has been based in Lichtervelde since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 17,386 € and equity of 522,667 €; its revenue is not published. With 1.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 35.0%, below the median of its sector (44.2%).
Companies similar to Marephar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek VAN Schepdael Retail sale of pharmaceutical products Wichelen · balance sheet €1.49m
- D5-Pharma Retail sale of pharmaceutical products Ganshoren · balance sheet €1.49m
- Pharmacie RENARDY Retail sale of pharmaceutical products Herve · balance sheet €1.50m
- DE Luchthaven Apotheek Retail sale of pharmaceutical products Zaventem · balance sheet €1.50m
- ENBA Retail sale of pharmaceutical products Bonheiden · balance sheet €1.48m
- Binche Pharma Retail sale of pharmaceutical products Binche · balance sheet €1.51m
- Pharmart Retail sale of pharmaceutical products Etterbeek · balance sheet €1.51m
- VAN Holder Stephan Retail sale of pharmaceutical products Zottegem · balance sheet €1.48m
Frequently asked questions about Marephar
What is the revenue of Marephar?
Marephar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Marephar?
In Belgium, the VAT number is the company number prefixed with BE: BE0479955109 for Marephar, if the company is VAT-registered. Its company number (CBE) is 0479.955.109.
Where is the registered office of Marephar?
According to the CBE register, the registered office of Marephar is in 8810 Lichtervelde.
What is the equity of Marephar?
At the close of the 2025 financial year, the equity of Marephar amounts to 522,667 €, a solvency of 35.0% of total assets.
How many people work at Marephar?
1.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Marephar?
The register lists 1 active mandates at Marephar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Marephar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →